Sandoz Specialty Summit 2024: Advancing patient access to quality treatments in Vietnam
Sandoz Vietnam, the wholly owned subsidiary of the global leader in generic and biosimilar medicines, today announced its inaugural Specialty…
Sandoz Vietnam, the wholly owned subsidiary of the global leader in generic and biosimilar medicines, today announced its inaugural Specialty…
Sandoz, the global leader in generic and biosimilar medicines today announced the launch of its inaugural Community Program on Antimicrobial…
Partnership reinforces commitment of Sandoz to reducing cancer burden in Vietnam Second such partnership with a Vietnamese hospital to improve…
World-leader in biosimilar and generic pharmaceuticals secures Vietnam business license Sandoz, the global leader in generic and biosimilar medicines, has…
Sandoz, the global leader in generic and biosimilar medicines, today celebrates the start of share trading on the SIX Swiss…
Sandoz Vietnam, the wholly owned subsidiary of the global leader in generic and biosimilar medicines, today announced its inaugural Specialty…
Sandoz, the global leader in generic and biosimilar medicines today announced the launch of its inaugural Community Program on Antimicrobial…
Partnership reinforces commitment of Sandoz to reducing cancer burden in Vietnam Second such partnership with a Vietnamese hospital to improve…
World-leader in biosimilar and generic pharmaceuticals secures Vietnam business license Sandoz, the global leader in generic and biosimilar medicines, has…
Sandoz, the global leader in generic and biosimilar medicines, today celebrates the start of share trading on the SIX Swiss…